News Release
- What's News July 24, 2023 Results of a Phase 3 study of Amifampridine phosphate (3,4-diaminopyridine) for Lambert-Eaton myasthenia syndrome (LEMS) in Japan
- What's News July 15, 2022 Acquisition of Marketing Licenses for Pharmaceuticals
- Product-related December 6, 2021 Phase 3 Clinical Trial（LEMS）
- Product-related June 28, 2021 Singed a license agreement.（LEMS）
- Product-related January 15, 2021 Singed a license agreement.（LCAT）
- What's News April 3, 2019 DyDo Pharma website launched.